Abbas Azadmehr
Overview
Explore the profile of Abbas Azadmehr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pooshani S, Azadmehr A, Saadat P, Sepidarkish M, Daraei A
Int J Neurosci
. 2024 Aug;
:1-10.
PMID: 39207776
Introduction: A growing body of strong evidence shows that the dysfunction of miRNAs plays key roles in the development and progression of Parkinson's disease (PD), however, little data has been...
2.
Saleki K, Mojtahedi Z, Ulrichs T, Mahdavi M, Azadmehr A
Front Immunol
. 2024 Jun;
15:1429908.
PMID: 38846941
No abstract available.
3.
Saleki K, Aram C, Alijanizadeh P, Khanmirzaei M, Vaziri Z, Ramzankhah M, et al.
Heliyon
. 2024 May;
10(10):e30898.
PMID: 38803919
Background: The initiator of cytokine storm in Coronavirus disease (COVID-19) is still unknown. We recently suggested a complex interaction of matrix metalloproteinases (MMPs), Fas ligand (FasL), and viral entry factors...
4.
Seyfi S, Azadmehr A, Ezoji K, Nabipour M, Babazadeh A, Saleki K, et al.
Interdiscip Perspect Infect Dis
. 2023 Nov;
2023:9048749.
PMID: 38025794
Background: Achieving a suitable medical laboratory index is very important for the prediction of clinical outcome of COVID-19 patients hospitalized to the intensive care unit (ICU). The correlation between neutrophil-to-lymphocyte...
5.
Shadkam R, Saadat P, Azadmehr A, Chehrazi M, Daraei A
Mol Neurobiol
. 2023 Nov;
61(5):2854-2865.
PMID: 37946005
Research findings show that genetic susceptibility to sporadic Parkinson's disease (PD), a common neurodegenerative disorder, is determined through gene variation of loci involved in its development and pathogenesis. A growing...
6.
Vaziri Z, Saleki K, Aram C, Alijanizadeh P, Pourahmad R, Azadmehr A, et al.
Biomed Pharmacother
. 2023 Oct;
168:115686.
PMID: 37839109
Cancer and cardiovascular disorders are known as the two main leading causes of mortality worldwide. Cardiotoxicity is a critical and common adverse effect of cancer-related chemotherapy. Chemotherapy-induced cardiotoxicity has been...
7.
Hamidi N, Feizi F, Azadmehr A, Zabihi E, Khafri S, Zarei-Behjani Z, et al.
Biotech Histochem
. 2023 Oct;
98(8):584-592.
PMID: 37779489
Bleomycin (BL) is a widely used anticancer drug that can cause pulmonary fibrosis due to increased fibroblast proliferation and increased secretion of extracellular matrix. is a tumor suppressor gene that...
8.
Saleki K, Alijanizadeh P, Azadmehr A
Biomed Pharmacother
. 2023 Sep;
167:115558.
PMID: 37748412
A major immunopathological feature of Coronavirus disease-2019 (COVID-19) is excessive inflammation in the form of "cytokine storm". The storm is characterized by injurious levels of cytokines which form a complicated...
9.
Maghsadi Z, Azadmehr A, Moghadamnia A, Feizi F, Hamidi N
Res Pharm Sci
. 2023 Mar;
18(2):177-184.
PMID: 36873280
Background And Purpose: Pulmonary fibrosis (PF) is a chronic and life-threatening interstitial lung disease. N-acetyl cysteine (NAC) is an antioxidant pharmaceutically available to reduce endothelial dysfunction, inflammation, and fibrosis, however,...
10.
Saleki K, Shirzad M, Javanian M, Mohammadkhani S, Alijani M, Miri N, et al.
Front Immunol
. 2022 Sep;
13:947401.
PMID: 36119078
Finding cytokine storm initiator factors associated with uncontrolled inflammatory immune response is necessary in COVID-19 patients. The aim was the identification of Fas/Fas Ligand (FasL) role in lung involvement and...